Published in West J Med on January 01, 1995
Basic medical advice for travelers to high altitudes. Dtsch Arztebl Int (2011) 1.25
High-altitude pulmonary edema at a ski resort. West J Med (1996) 0.97
Factors affecting a climber's ability to ascend Mont Blanc. Eur J Appl Physiol (2005) 0.85
Prevention and Treatment of High-altitude Illness in Travelers. Curr Infect Dis Rep (2004) 0.82
Population level determinants of acute mountain sickness among young men: a retrospective study. BMC Public Health (2011) 0.79
Correlation between blood pressure changes and AMS, sleeping quality and exercise upon high-altitude exposure in young Chinese men. Mil Med Res (2014) 0.79
Benzolamide improves oxygenation and reduces acute mountain sickness during a high-altitude trek and has fewer side effects than acetazolamide at sea level. Pharmacol Res Perspect (2016) 0.76
Intermittent hypoxia training as non-pharmacologic therapy for cardiovascular diseases: Practical analysis on methods and equipment. Exp Biol Med (Maywood) (2016) 0.75
Acute mountain sickness. J R Soc Med (1996) 0.75
High altitude pilgrimage medicine. High Alt Med Biol (2014) 0.75
Moving on up: is it safe for patients to relocate to higher altitude following the fontan procedure? Pediatr Cardiol (2012) 0.75
[Arterial hypertension due to altitude]. Wien Med Wochenschr (2008) 0.75
Working in permanent hypoxia for fire protection-impact on health. Int Arch Occup Environ Health (2003) 0.75
Reference spirometric values using techniques and equipment that meet ATS recommendations. Am Rev Respir Dis (1981) 10.89
The incidence, importance, and prophylaxis of acute mountain sickness. Lancet (1976) 5.69
Acute mountain sickness in a general tourist population at moderate altitudes. Ann Intern Med (1993) 3.63
Will mountains trekkers have heart attacks? JAMA (1989) 1.88
Acute mountain sickness and acetazolamide. Clinical efficacy and effect on ventilation. JAMA (1982) 1.88
Arterial oxygen tension in relation to age in healthy subjects. Respiration (1968) 1.84
Incidence of acute mountain sickness at intermediate altitude. JAMA (1989) 1.25
The relationship between acute mountain sickness and pulmonary ventilation at 2,835 meters (9,300 ft). Chest (1979) 1.01
Short-term adaptation to moderate altitude. Patients with chronic obstructive pulmonary disease. JAMA (1978) 1.01
CHANGES IN ALVEOLAR AND ARTERIAL GAS TENSIONS AS RELATED TO ALTITUDE AND AGE. J Appl Physiol (1964) 0.99
Adoption to high altitude: changes in lung volumes during the first seven days at Mt. Evans, Colorado. J Appl Physiol (1953) 0.98
The causes of death among trekkers in Nepal. Int J Sports Med (1992) 0.93
Vital capacity, exercise performance, and blood gases at altitude as related to age. J Appl Physiol Respir Environ Exerc Physiol (1980) 0.92
The coronary stress of skiing at high altitude. Arch Intern Med (1990) 0.87
Study of cardiopulmonary function on exposure to high altitude. I. Acute acclimatization to an altitude of 3,5000 to 4,000 meters in relation to altitude sickness and cardiopulmonary function. Am Rev Respir Dis (1972) 0.83
Personal use of drug samples by physicians and office staff. JAMA (1997) 6.82
Community education for cardiovascular health. Lancet (1977) 6.32
Treatment of chronic stable angina. A preliminary report of survival data of the randomized Veterans Administration cooperative study. N Engl J Med (1977) 3.06
The campomelic syndrome: review, report of 17 cases, and follow-up on the currently 17-year-old boy first reported by Maroteaux et al in 1971. Am J Med Genet (1983) 2.53
Cerebral form of high-altitude illness. Lancet (1975) 2.49
Purification and specificity of cellobiose phosphorylase from Clostridium thermocellum. J Biol Chem (1968) 2.31
Elevated levels of hyaluronic acid in the sera of women with fibromyalgia. J Rheumatol (1997) 2.15
Second messenger cascade specificity and pharmacological selectivity of the human P2Y1-purinoceptor. Br J Pharmacol (1996) 2.12
Recurrent urinary infections in girls: relation to enuresis. Can Med Assoc J (1972) 2.09
Early reference to air reduction of intussusception. Can Assoc Radiol J (1993) 2.05
A pilot study of a long acting somatostatin analogue for the treatment of refractory rheumatoid arthritis. Ann Rheum Dis (2001) 2.05
Association of HLA-Aw31 and HLA-DR1 with adult rheumatoid arthritis. Ann Rheum Dis (1982) 1.99
SAPHO syndrome. Dermatology (1993) 1.97
Effect of spa therapy in Tiberias on patients with rheumatoid arthritis and osteoarthritis. J Rheumatol (1991) 1.94
Eager communities and reluctant doctors. N Engl J Med (1968) 1.93
P2-purinergic receptors: subtype-associated signaling responses and structure. Annu Rev Pharmacol Toxicol (1995) 1.84
Expression of a cloned P2Y purinergic receptor that couples to phospholipase C. Mol Pharmacol (1994) 1.76
Purification and properties of beta-1,4-oligoglucan:orthophosphate glucosyltransferase from Clostridium thermocellum. J Biol Chem (1969) 1.76
Agonist action of adenosine triphosphates at the human P2Y1 receptor. Mol Pharmacol (1998) 1.74
Serological and bacteriological investigations of chickens from flocks naturally infected with Salmonella enteritidis. Vet Rec (1989) 1.65
Severity of lung disease in Indian children. Can Med Assoc J (1979) 1.64
Effect of acetazolamide on hypoxemia during sleep at high altitude. N Engl J Med (1979) 1.64
Cardiac arrest due to oral potassium administration. Am J Med (1975) 1.64
A mutational analysis of residues essential for ligand recognition at the human P2Y1 receptor. Mol Pharmacol (1997) 1.63
Techniques for application of faecal DNA methods to field studies of Ursids. Mol Ecol (1997) 1.62
Oxidation of glycerol differentiates African from European isolates of Mycoplasma mycoides subspecies mycoides SC (small colony) Vet Rec (1997) 1.61
Operation Everest II: oxygen transport during exercise at extreme simulated altitude. J Appl Physiol (1985) (1988) 1.60
The cardiac pathology of chronic exogenous obesity. Circulation (1965) 1.59
HEK293 human embryonic kidney cells endogenously express the P2Y1 and P2Y2 receptors. Neuropharmacology (1997) 1.59
Rapid resolution of pulmonary thromboemboli in man. An angiographic study. JAMA (1966) 1.57
Operation Everest II: elevated high-altitude pulmonary resistance unresponsive to oxygen. J Appl Physiol (1985) (1987) 1.56
Utilization of glucose by Clostridium thermocellum: presence of glucokinase and other glycolytic enzymes in cell extracts. J Bacteriol (1971) 1.55
Mediastinal emphysema in mountain climbers: report of two cases and review. Heart Lung (1977) 1.54
Sarcoidosis: TB or not TB? Ann Rheum Dis (2002) 1.54
The role of amino acids in extracellular loops of the human P2Y1 receptor in surface expression and activation processes. J Biol Chem (1999) 1.54
Quality of life after bypass surgery for unstable angina. 5-year follow-up results of a Veterans Affairs Cooperative Study. Circulation (1991) 1.53
Reduction in the rate of diastolic descent of the mitral valve echogram in patients with altered left ventricular diastolic pressure-volume relations. Circulation (1974) 1.49
The Veterans Administration Cooperative Study of stable angina: current status. Circulation (1982) 1.49
Sarcoidosis presenting as primary Sjogren's syndrome. Isr Med Assoc J (2001) 1.47
Detection of salmonella. Vet Rec (1990) 1.46
Primary pulmonary hypertension favorable effect of isoproterenol. N Engl J Med (1976) 1.46
Minor anatomic abnormalities of the hip joint persisting from childhood and their possible relationship to idiopathic osteoarthrosis. Clin Orthop Relat Res (1991) 1.45
Influence of acute changes in preload, afterload, contractile state and heart rate on ejection and isovolumic indices of myocardial contractility in man. Circulation (1976) 1.44
Outcome of surgical treatment for superficial dyspareunia from vulvar vestibulitis. J Reprod Med (2001) 1.44
ATP, an agonist at the rat P2Y(4) receptor, is an antagonist at the human P2Y(4) receptor. Mol Pharmacol (2000) 1.44
Echocardiographic determination of left ventricular stress-velocity relations. Circulation (1975) 1.44
Operation Everest II: preservation of cardiac function at extreme altitude. J Appl Physiol (1985) (1987) 1.42
Direct coronal high resolution computed tomography of the temporomandibular joints in patients with rheumatoid arthritis. J Rheumatol (1989) 1.42
Left ventricular compliance: mechanisms and clinical implications. Am J Cardiol (1976) 1.41
Open thoracotomy procedural competency: validity study of teaching and assessment modalities. Ann Emerg Med (1996) 1.41
Saskatchewan's role in radiotherapy research. Can Med Assoc J (1985) 1.39
Echocardiographic assessment of left ventricular function with special reference to normalized velocities. Circulation (1974) 1.36
Circulatory adaptation to high altitude. Annu Rev Med (1968) 1.32
Retinal hemorrhage at high altitude. N Engl J Med (1970) 1.31
The cost to the central nervous system of climbing to extremely high altitude. N Engl J Med (1989) 1.30
The snowboarder's foot and ankle. Am J Sports Med (1998) 1.29
The effects of methotrexate on the production and activity of interleukin-1. Arthritis Rheum (1989) 1.28
Efficacy and safety of diacerein in osteoarthritis of the knee: a double-blind, placebo-controlled trial. The Diacerein Study Group. Arthritis Rheum (2000) 1.28
Control of acute mountain sickness. Aerosp Med (1971) 1.27
Stimulation of prostaglandin E production in cultured human fibroblasts by poly(I)-poly(C) and human interferon. Nature (1977) 1.27
Abnormal circulatory responses to high altitude in subjects with a previous history of high-altitude pulmonary edema. Circulation (1971) 1.27
Crystal structure of a deacylation-defective mutant of penicillin-binding protein 5 at 2.3-A resolution. J Biol Chem (2001) 1.26
The incidence of fracture of the proximal femur in two million Canadians from 1972 to 1984. Projections for Canada in the year 2006. Clin Orthop Relat Res (1991) 1.26
The effects of leucovorin (folinic acid) on methotrexate therapy in rheumatoid arthritis patients. Arthritis Rheum (1988) 1.25
Accelerated nodulosis and vasculitis during methotrexate therapy for rheumatoid arthritis. Arthritis Rheum (1988) 1.25
Patients' perceptions of hospital care. Hospitals (1972) 1.24
Prinzmetal's variant angina: hemodynamic and angiographic observations during pain. Am J Cardiol (1975) 1.24
Alteration in the amino acid content of yeast during growth under various nutritional conditions. J Bacteriol (1969) 1.23
Minocycline-induced autoimmune syndromes: an overview. Semin Arthritis Rheum (1999) 1.23
The cloning and sequencing of the genes encoding phytase (phy) and pH 2.5-optimum acid phosphatase (aph) from Aspergillus niger var. awamori. Gene (1993) 1.23
Heart sounds in patients with homograft replacement of the mitral valve. Circulation (1970) 1.21
Operation Everest. II: Nutrition and body composition. J Appl Physiol (1985) (1988) 1.20
Left atrial enlargement. Echocardiographic assessment of electrocardiographic criteria. Circulation (1976) 1.20
Survival in subgroups of patients with left main coronary artery disease. Veterans Administration Cooperative Study of Surgery for Coronary Arterial Occlusive Disease. Circulation (1982) 1.18
Prevalence and characteristics of the aortic ejection sound in adults. Am J Cardiol (1988) 1.18
Identification of the active site in penicillin-binding protein 3 of Escherichia coli. J Bacteriol (1985) 1.16
Elevated tear interleukin-6 levels in patients with Sjögren syndrome. Ophthalmology (1998) 1.16
Differential coupling of the human P2Y(11) receptor to phospholipase C and adenylyl cyclase. Br J Pharmacol (2001) 1.15
Psoriatic arthritis: interrelationships between skin and joint manifestations related to onset, course and distribution. Clin Rheumatol (2000) 1.15
The septic milieu triggers expression of spliced tissue factor mRNA in human platelets. J Thromb Haemost (2011) 1.15
Arteriographic assessment of lung scanning in the diagnosis of pulmonary thromboembolism. N Engl J Med (1966) 1.14
An unusual complication of intrauterine transfusion. Can Med Assoc J (1966) 1.14
High altitude pulmonary edema. Epidemiologic observations in Peru. Chest (1978) 1.13
Operation Everest II: structural adaptations in skeletal muscle in response to extreme simulated altitude. Acta Physiol Scand (1991) 1.13
Cloning and characterization of the ponA gene encoding penicillin-binding protein 1 from Neisseria gonorrhoeae and Neisseria meningitidis. J Bacteriol (1997) 1.11
Association between gold induced skin rash and remission in patients with rheumatoid arthritis. Ann Rheum Dis (1989) 1.11
Fluoxetine and amitriptyline inhibit nitric oxide, prostaglandin E2, and hyaluronic acid production in human synovial cells and synovial tissue cultures. Arthritis Rheum (1999) 1.11
Subnormal cardiac output at rest and during exercise in residents at 3,100 m altitude. J Appl Physiol (1967) 1.11
Interrelationship between stimulation of prostaglandin E and hyaluronate production by poly (I) . poly (C) and interferon in synovial fibroblast culture. Arthritis Rheum (1979) 1.11
Acute myocardial infarction associated with high dose intravenous immunoglobulin infusion for autoimmune disorders. A study of four cases. Ann Rheum Dis (2000) 1.09
Vaccination of chickens with chicken-derived Salmonella enteritidis phage type 4 aroA live oral Salmonella vaccines. Vaccine (1992) 1.09
Surgical management of Prinzmetal's variant angina. Chest (1974) 1.09
Recurrent infective endocarditis: analysis of predisposing factors and clinical features. Am J Med (1979) 1.09
Suppression of defects in cyclic adenosine 3',5'-monophosphate metabolism in Escherichia coli. J Bacteriol (1980) 1.09
Regional and total body bone mineral content, bone mineral density, and total body tissue composition in children 8-16 years of age. Calcif Tissue Int (1993) 1.08
Fidelity in functional coupling of the rat P2Y1 receptor to phospholipase C. Br J Pharmacol (1997) 1.08
Operation Everest II: arterial oxygen saturation and sleep at extreme simulated altitude. Am Rev Respir Dis (1992) 1.08
Validation study of a Hebrew version of WOMAC in patients with osteoarthritis of the knee. Clin Rheumatol (1999) 1.08